Back

Infection drives excessive platelet inhibition during P2Y12 inhibitor therapy in coronary artery disease

30 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Residual risk in ischaemic heart disease: thrombotic and vascular mechanisms Thrombosis, Platelets, and Coagulation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Lukas Johannes Weiss

University Hospital Wuerzburg, Wuerzburg (Germany)

5 More presentations in this session

Presentation thumbnail
Platelet dysfunction, liver fibrosis and adverse outcomes in individuals with ischemic heart disease: a post-hoc analysis of the prospective observational EVA study
Doctor G. Guadalupi (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Effects of icosapent ethyl on coagulation biomarkers and their association with event‑free survival in high‑risk cardiovascular patients: a post hoc analysis of the REDUCE-IT
Ms A. Kuenzli (Schlieren, CH)
Abstract Slides Video
Presentation thumbnail
Hypertension-associated acetate deficiency enhances platelet activation and thrombosis via Olfr78
Doctor Y. Chen (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
A dense fibrin network favours layered plaque formation in the infarct-related artery in patients with ST-segment elevation myocardial infarction
Doctor K. Karwat (Krakow, PL)
Abstract Slides Video
Presentation thumbnail
S1P as a novel target to address adverse outcomes following acute myocardial infarction
Miss E. Pavlidou (Schlieren, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Residual risk in ischaemic heart disease: thrombotic and vascular mechanisms

The Event

Event poster

ESC Congress 2026

30 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Session
Antithrombotic therapies in patients with severe infections: COVID-19 and more
25 August 2023
thumbnail
Congress Presentation
Sex-related variations in platelet reactivity in presence or absence of antiplatelet therapy
30 August 2025
thumbnail
Congress Presentation
Multi-level thromboinflammatory activation after TAVR: systemic, cellular, and platelet transcriptomic changes
29 August 2026
thumbnail
Congress Presentation
Integrated Impact of hs-CRP, LDL-C and Lp(a) on Platelet Reactivity in Coronary Heart Disease Patients Receiving Dual Antiplatelet Therapy
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources